Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stability

Human Gene Therapy Methods

Volumn 25, Issue 2, 2014, Pages 154-165

  Kueberuwa, Gray ^a   Cawood, Ryan ^a   Tedcastle, Alison ^a   Seymour, Leonard W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 133A; MICRORNA 142 3P; MICRORNA 206; ONCOLYTIC SINDBIS VIRUS; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DNA RESPONSIVE ELEMENT; GENE INSERTION; GENE MUTATION; GENETIC CODE; GENETIC STABILITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER; MACROPHAGE; MOUSE; MUSCLE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REPORTER GENE; RNA VIRUS; TISSUE SPECIFICITY; TRANSGENE; VIRUS GENOME; VIRUS REPLICATION; ANIMAL; CELL LINE; CYTOLOGY; GENETICS; GENOMIC INSTABILITY; HAMSTER; HEK293 CELL LINE; HEMATOPOIETIC STEM CELL; METABOLISM; PHYSIOLOGY; SINDBIS VIRUS; VIROLOGY;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; CRICETINAE; GENOME, VIRAL; GENOMIC INSTABILITY; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; LIVER; MICE; MICRORNAS; MUSCLES; ONCOLYTIC VIRUSES; RESPONSE ELEMENTS; SINDBIS VIRUS;

EID: 84898760301     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2013.202     Document Type: Article

References (55)

1. Adams, R.H., and Brown, D.T. (1985). BHK cells expressing Sindbis virus-induced homologous interference allow the translation of nonstructural genes of superinfecting virus. J. Virol. 54, 351-357
2. Altmanhamamdzic, S., et al. (1997). Expression of beta-galactosidase in mouse brain: Utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system. Gene Ther. 4, 815-822
3. Arbuthnot, P., and Thompson, L.J. (2008). Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J. Gastroenterol. 14, 1670-1681
4. Assunçaö-Miranda, I., Bozza, M.T., and Da Poian, A.T. (2010). Pro-inflammatory response resulting from sindbis virus infection of human macrophages: Implications for the pathogenesis of viral arthritis. J. Med. Virol. 82, 164-174
5. Barr, J.N., and Fearns, R. (2010). How RNA viruses maintain their genome integrity. J. Gen. Virol. 91, 1373-1387
6. Bazan-Peregrino, M., et al. (2008). Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus. Hum. Gene Ther. 19, 873-886
7. Brown, B.D., et al. (2006). Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 12, 585-591
8. Brown, J.D., et al. (2010). Ribosome ''Skipping'': ''Stop-Carry On'' or ''StopGo'' translation recoding: Expansion of decoding rules enriches gene expression. In Nucleic Acids and Molecular Biology. J.M. Bujnicki, ed. (Springer, New York), pp. 101-121
9. Cawood, R., et al. (2009). Use of tissue-specific microRNA to control pathology of wild-Type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog. 5, e1000440
10. Cook, S.H., and Griffin, D.E. (2003). Luciferase imaging of neurotropic viral infection in intact animals. J. Virol. 77, 5333-5338
11. Cooper, P.D., et al. (1974). On the nature of poliovirus genetic recombinants. J. Gen. Virol. 23, 41-49
12. Davoren, P., et al. (2008). Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol. Biol. 9, 76
13. Dickson, A.M., et al. (2012). Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm. J. Biol. Chem. 287, 36229-36238
14. Donnelly, M.L.L., et al. (2001). Analysis of the aphthovirus 2A/ 2B polyprotein ''cleavage'' mechanism indicates not a proteolytic reaction, but a novel translational effect: A putative ribosomal ''skip.'' J. Gen. Virol. 82, 1013-1025
15. Durbin, R.K., and Stollar, V. (1986). Sequence-Analysis of the E2 gene of a hyperglycosylated, host restricted mutant of sindbis virus and estimation of mutation-rate from frequency of revertants. Virology 154, 135-143
16. Edge, R.E., et al. (2008). A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol. Ther. 16, 1437-1443
17. Esquela-Kerscher, A., and Slack, F.J. (2006). Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269
18. Frolov, I., Hardy, R., and Rice, C.M. (2001). Cis-Acting RNA elements at the 5¢ end of Sindbis virus genome RNA regulate minus-And plus-strand RNA synthesis. RNA 7, 1638-1651
19. Giraldez, A.J., et al. (2006). Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312, 75-79
20. Granot, T., and Meruelo, D. (2012). The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan. Cancer Gene Ther. 19, 588-591
21. Hahn, C.S., et al. (1992). Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc. Natl. Acad. Sci. USA 89, 2679-2683
22. Heo, J., et al. (2013). Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat. Med. 19, 329-336
23. Hu, J.C.C., et al. (2006). A phase I STUDY of OncoVEXGMCSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. Clin. Cancer Res. 12, 6737-6747
24. Huang, P-Y., Guo, J-H., and Hwang, L-H. (2011). Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo. Mol. Ther. 20, 298-305
25. Jan, J-T., Chatterjee, S., and Griffin, D.E. (2000). Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 74, 6425-6432
26. Johnston, R.E., Wan, K., and Bose, H.R. (1974). Homologous interference induced by sindbis virus. J. Virol. 14, 1076-1082
27. Kelly, E.J., and Russell, S.J. (2009). MicroRNAs and the regulation of vector tropism. Mol. Ther. 17, 409-416
28. Kelly, E.J., et al. (2008). Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14, 1278-1283
29. Kurkela, S., et al. (2004). Causative agent of pogosta disease isolated from blood and skin lesions. Emerg. Infect. Dis. 10, 889-894
30. Kurkela, S., et al. (2005). Clinical and laboratory manifestations of Sindbis virus infection: Prospective study, Finland, 2002-2003. J. Infect. Dis. 191, 1820-1829
31. Laine, M., et al. (2000). Prolonged arthritis associated with Sindbis-related (Pogosta) virus infection. Rheumatology 39, 1272-1274
32. Landgraf, P., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414
33. Lanni, P., et al. (2013). The innovative evolution of cancer gene and cellular therapies. Cancer Gene Ther. 20, 141-149
34. Liu, J., et al. (2004). Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437-1441
35. Luukkainen, R., Laine, M., and Nirhamo, J. (2000). Chronic arthritis after Sindbis-related (Pogosta) virus infection. Scand. J. Rheumatol. 29, 399-400
36. Mansour, M., Palese, P., and Zamarin, D. (2011). Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells. J. Virol. 85, 6015-6023
37. Marchesi, V. (2013). Immunotherapy: Oncolytic vaccinia virus shows promise in liver cancer. Nat. Rev. Clin. Oncol. 10, 182
38. Mathonnet, G.R., et al. (2007). MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317, 1764-1767
39. Petersen, C.P., et al. (2006). Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 21, 533-542
40. Postic, B., et al. (1969). Two variants of Sindbis virus which differ in interferon induction and serum clearance. J. Infect. Dis. 120, 339
41. Raju, R., Subramaniam, S.V., and Hajjou, M. (1995). Genesis of sindbis virus by in-vivo recombination of nonreplicative rna precursors. J. Virol. 69, 7391-7401
42. Rehwinkel, J.A.N., et al. (2005). A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11, 1640-1647
43. Roberts, M.S., et al. (2006). Naturally occurring viruses for the treatment of cancer. Discov. Med. 6, 217-222
44. Rümenapf, T., Strauss, E.G., and Strauss, J.H. (1994). Subgenomic mRNA of Aura alphavirus is packaged into virions. J. Virol. 68, 56-62
45. Ryman, K.D., et al. (2000). Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74, 3366-3378
46. Saito, K., et al. (2009). Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses. Oral Oncol. 45, 1021-1027
47. Sane, J., et al. (2012). Prolonged Myalgia in Sindbis virus infection: Case description and in vitro infection of myotubes and myoblasts. J. Infect. Dis. 206, 407-414
48. Strauss, J.H., and STRAUSS, E.G. (1994). The alphaviruses-gene- expression, replication, and evolution. Microbiol. Rev. 58, 491-562
49. Thomas, J.M., et al. (2003). Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J. Virol. 77, 5598-5606
50. Tseng, J.C., et al. (2004). Systemic tumor targeting and killing by Sindbis viral vectors. Nat. Biotechnol. 22, 70-77
51. Turell, M.J. (1988). Horizontal and vertical transmission of viruses by insect by and tick vectors. In The Arboviruses: Epidemiology and Ecology, Volume 1. T.P. Monath, ed. (CRC Press, Boca Raton, FL), pp 127-154
52. Turell, M.J., Lundstrom, J.O., and Niklasson, B. (1990). Transmission of Ockelbo virus by Aedes-Cinereus, Ae-Communis, and Ae-Excrucians (Diptera, Culicidae) collected in an enzootic area in central Sweden. J. Med. Entomol. 27, 266-268
53. Urbanowicz, A., et al. (2005). Homologous crossovers among molecules of brome mosaic bromovirus RNA1 or RNA2 segments in vivo. J. Virol. 79, 5732-5742
54. Verheije, M.H., and Rottier, P.J.M. (2012). Retargeting of viruses to generate oncolytic agents. Adv. Virol. 2012, 798526
55. Zhang, J., Frolov, I., and Russell, S.J. (2004). Gene therapy for matignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. J. Gene. Med. 6, 1082-1091